Ellen Moscoe1, Jacob Bor2, Till Bärnighausen3. 1. Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue Building 1, room 1104, Boston, MA, USA. Electronic address: eem571@mail.harvard.edu. 2. Department of Global Health, Boston University School of Public Health, 801 Massachusetts Ave, 3rd Floor, Boston, MA, USA; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, P.O. Box 198, Mtubatuba, 3935, South Africa. 3. Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue Building 1, room 1104, Boston, MA, USA; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, P.O. Box 198, Mtubatuba, 3935, South Africa.
Abstract
OBJECTIVES: Regression discontinuity (RD) designs allow for rigorous causal inference when patients receive a treatment based on scoring above or below a cutoff point on a continuously measured variable. We provide an introduction to the theory of RD and a systematic review and assessment of the RD literature in medicine, epidemiology, and public health. STUDY DESIGN AND SETTING: We review the necessary conditions for valid RD results, provide a practical guide to RD implementation, compare RD to other methodologies, and conduct a systematic review of the RD literature in PubMed. RESULTS: We describe five key elements of analysis all RD studies should report, including tests of validity conditions and robustness checks. Thirty two empirical RD studies in PubMed met our selection criteria. Most of the 32 RD articles analyzed the effectiveness of social policies or mental health interventions, with only two evaluating clinical interventions to improve physical health. Seven out of the 32 studies reported on all the five key elements. CONCLUSION: Increased use of RD provides an exciting opportunity for obtaining unbiased causal effect estimates when experiments are not feasible or when we want to evaluate programs under "real-life" conditions. Although treatment eligibility in medicine, epidemiology, and public health is commonly determined by threshold rules, use of RD in these fields has been very limited until now.
OBJECTIVES: Regression discontinuity (RD) designs allow for rigorous causal inference when patients receive a treatment based on scoring above or below a cutoff point on a continuously measured variable. We provide an introduction to the theory of RD and a systematic review and assessment of the RD literature in medicine, epidemiology, and public health. STUDY DESIGN AND SETTING: We review the necessary conditions for valid RD results, provide a practical guide to RD implementation, compare RD to other methodologies, and conduct a systematic review of the RD literature in PubMed. RESULTS: We describe five key elements of analysis all RD studies should report, including tests of validity conditions and robustness checks. Thirty two empirical RD studies in PubMed met our selection criteria. Most of the 32 RD articles analyzed the effectiveness of social policies or mental health interventions, with only two evaluating clinical interventions to improve physical health. Seven out of the 32 studies reported on all the five key elements. CONCLUSION: Increased use of RD provides an exciting opportunity for obtaining unbiased causal effect estimates when experiments are not feasible or when we want to evaluate programs under "real-life" conditions. Although treatment eligibility in medicine, epidemiology, and public health is commonly determined by threshold rules, use of RD in these fields has been very limited until now.
Authors: Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen Journal: Curr Opin HIV AIDS Date: 2015-11 Impact factor: 4.283
Authors: Michael R Law; Lucy Cheng; Heather Worthington; Muhammad Mamdani; Kimberlyn M McGrail; Fiona K I Chan; Sumit R Majumdar Journal: CMAJ Date: 2017-05-15 Impact factor: 8.262
Authors: June Stevens; Charlotte Pratt; Josephine Boyington; Cheryl Nelson; Kimberly P Truesdale; Dianne S Ward; Leslie Lytle; Nancy E Sherwood; Thomas N Robinson; Shirley Moore; Shari Barkin; Ying Kuen Cheung; David M Murray Journal: Am J Prev Med Date: 2016-10-26 Impact factor: 5.043
Authors: Alyssa F Harlow; Jacob Bor; Alana T Brennan; Mhairi Maskew; William MacLeod; Sergio Carmona; Koleka Mlisana; Matthew P Fox Journal: Am J Epidemiol Date: 2020-12-01 Impact factor: 4.897